Baker Brothers Advisors - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$7,957,373
-16.5%
1,671,7170.0%0.05%
-11.5%
Q1 2023$9,528,787
+337.8%
1,671,717
+675.0%
0.05%
+300.0%
Q4 2022$2,176,363
-55.0%
215,6950.0%0.01%
-59.4%
Q3 2022$4,834,000215,6950.03%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$197,709,00022.51%
Redmile Group, LLC 12,957,222$758,127,00017.24%
Grosvenor Holdings, L.L.C. 1,037,256$60,690,0006.28%
Casdin Capital, LLC 3,400,000$198,934,0005.61%
Ally Bridge Group (NY) LLC 270,000$15,798,0005.52%
DAFNA Capital Management LLC 372,160$21,775,0005.48%
Tri Locum Partners LP 142,032$8,310,0003.27%
Kynam Capital Management, LP 95,561$5,591,0002.99%
Artal Group S.A. 1,800,000$105,318,0002.86%
Bellevue Group AG 3,775,736$220,918,0002.28%
View complete list of FATE THERAPEUTICS INC shareholders